enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Stem cell therapy for macular degeneration - Wikipedia

   en.wikipedia.org/wiki/Stem_cell_therapy_for...

   Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]

3. Human embryonic stem cells clinical trials - Wikipedia

   en.wikipedia.org/wiki/Human_embryonic_stem_cells...

   Two clinical trials involving derivatives of human embryonic stem cells were approved in 2010. Advanced Cell Technology (ACT) located in Marlborough, Massachusetts, leads the trials aimed at improving the vision of patients with Stargardt's Macular Dystrophy and Dry Age-Related Macular Degeneration.

4. Astellas Institute for Regenerative Medicine - Wikipedia

   en.wikipedia.org/wiki/Astellas_Institute_for...

   On November 30, 2010, Ocata filed an Investigational New Drug application with the U.S. FDA for the first clinical trial using embryonic stem cells to regenerate retinal pigment epithelium to treat Dry Age-Related Macular Degeneration (Dry AMD). [17]

5. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

   www.aol.com/fda-approves-biosimilars-macular...

   Macular degeneration treatment is safe and effective. The FDA approval was based on a review of scientific evidence showing that both drugs are “highly similar” to Regeneron Pharmaceuticals’ ...

6. Dry macular degeneration takes longer to develop, but some ...

   www.aol.com/news/dry-macular-degeneration-takes...

   In dry macular degeneration, the concern is when deposits called drusen start getting out of control. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 ...

7. Masayo Takahashi - Wikipedia

   en.wikipedia.org/wiki/Masayo_Takahashi

   Masayo Takahashi (高橋 政代, Takahashi Masayo, born June 23, 1961) is a Japanese medical physician, ophthalmologist and stem cell researcher.. Takahashi serves as a project research leader at the Riken Center for Developmental Biology in Kobe focusing on the clinical application of iPS Cell (induced Pluripotent Stem Cell) technology on macular degeneration.